CO SB203 | 2024 | Regular Session

Status

Spectrum: Bipartisan Bill
Status: Engrossed on April 23 2024 - 50% progression
Action: 2024-04-23 - Introduced In House - Assigned to Health & Human Services
Pending: House Health and Human Services Committee
Hearing: Apr 29 @ 1:30 pm in Room Old State Library
Text: Latest bill text (Engrossed) [PDF]

Summary

Concerning requiring the Colorado prescription drug affordability review board to consider input from the Colorado rare disease advisory council under certain circumstances.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug Board Consider Rare Disease Advisory Council

Sponsors


Roll Calls


History

DateChamberAction
2024-04-23HouseIntroduced In House - Assigned to Health & Human Services
2024-04-23SenateSenate Third Reading Passed - No Amendments
2024-04-22SenateSenate Second Reading Special Order - Passed - No Amendments
2024-04-18SenateSenate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole
2024-04-08SenateIntroduced In Senate - Assigned to State, Veterans, & Military Affairs

Subjects


Colorado State Sources


Bill Comments

feedback